Table 4.
Variable | Mean ± SE Baseline Score | Mean ± SE 6-Wk Score | Mean ± SE 12-Wk Score | p Value |
---|---|---|---|---|
Physical health summary: | ||||
Placebo | 76.25 ± 5.59 | 74.73 ± 4.38 | 72.36 ± 5.45 | 0.869 |
Active | 64.25 ± 6.17 | 65.75 ± 6.56 | 66.92 ± 5.63 | 0.954 |
p Value | 0.161 | 0.272 | 0.497 | |
Mental health summary: | ||||
Placebo | 81.23 ± 4.62 | 77.37 ± 4.64 | 80.66 ± 4.87 | 0.817 |
Active | 69.67 ± 7.16 | 71.36 ± 5.62 | 77.18 ± 4.02 | 0.642 |
p Value | 0.186 | 0.416 | 0.584 | |
Physical functioning: | ||||
Placebo | 83.33 ± 5.53 | 82.14 ± 4.41 | 84.23 ± 3.34 | 0.952 |
Active | 71.67 ± 6.74 | 71.33 ± 6.96 | 78.33 ± 8.07 | 0.747 |
p Value | 0.192 | 0.208 | 0.528 | |
Physical health role limitation: | ||||
Placebo | 80 ± 9.82 | 71.67 ± 9.41 | 67.31 ± 12.46 | 0.69 |
Active | 63.33 ± 11.67 | 61.67 ± 11.41 | 56.67 ± 10.76 | 0.91 |
p Value | 0.284 | 0.504 | 0.522 | |
Body pain: | ||||
Placebo | 78 ± 5.37 | 74.33 ± 5.93 | 76.35 ± 5.31 | 0.893 |
Active | 66 ± 6.2 | 73 ± 7.33 | 74 ± 6.48 | 0.657 |
p Value | 0.155 | 0.889 | 0.786 | |
General health: | ||||
Placebo | 63.67 ± 5.24 | 65.67 ± 4.57 | 61.54 ± 5.2 | 0.848 |
Active | 56 ± 3.94 | 57 ± 6.15 | 58.67 ± 4.77 | 0.931 |
p Value | 0.252 | 0.268 | 0.687 | |
Energy/fatigue: | ||||
Placebo | 64 ± 5.65 | 63.67 ± 4.1 | 67.69 ± 4.62 | 0.819 |
Active | 50.67 ± 8.24 | 49.67 ± 7.28 | 54 ± 5.88 | 0.906 |
p Value | 0.193 | 0.105 | 0.085 | |
Social functioning: | ||||
Placebo | 94.17 ± 4.2 | 83.33 ± 6.06 | 89.42 ± 3.7 | 0.283 |
Active | 78.33 ± 9 | 78.33 ± 8.75 | 88.33 ± 5.38 | 0.589 |
p Value | 0.122 | 0.642 | 0.873 | |
Emotional problem role limitation: | ||||
Placebo | 82.22 ± 9.12 | 75.56 ± 10.01 | 76.92 ± 10.93 | 0.879 |
Active | 68.89 ± 11.02 | 75.56 ± 8.27 | 80 ± 7.83 | 0.691 |
p Value | 0.359 | 1 | 0.817 | |
Emotional well-being: | ||||
Placebo | 84.53 ± 2.7 | 86.93 ± 2.54 | 88.62 ± 2.43 | 0.542 |
Active | 80.8 ± 3.87 | 81.87 ± 3.53 | 79.43 ± 3.7 | 0.899 |
p Value | 0.435 | 0.254 | 0.052 |